BioNeutra Global Corp (BGA) - Total Liabilities

Latest as of September 2024: CA$21.81 Million CAD ≈ $15.77 Million USD

Based on the latest financial reports, BioNeutra Global Corp (BGA) has total liabilities worth CA$21.81 Million CAD (≈ $15.77 Million USD) as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of BioNeutra Global Corp to see how much of total assets are deployed in long-term investments.

BioNeutra Global Corp - Total Liabilities Trend (2013–2023)

This chart illustrates how BioNeutra Global Corp's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see BioNeutra Global Corp (BGA) total assets.

BioNeutra Global Corp Competitors by Total Liabilities

The table below lists competitors of BioNeutra Global Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Profusa, Inc. Common Stock NASDAQ:PFSA	USA	$29.06 Million
Chariot Oil & Gas Limited LSE:CHAR	UK	GBX6.44 Million
PHAXIAM Therapeutics S.A. PA:PHXM	France	€23.66 Million
Wynnstay Group Plc LSE:WYN	UK	GBX102.04 Million
The Alumasc Group plc LSE:ALU	UK	GBX45.48 Million
Sarawak Cable Bhd KLSE:5170	Malaysia	RM466.66 Million
Venture Life Group PLC LSE:VLG	UK	GBX17.76 Million
Centaurus Energy Inc V:CTA	Canada	CA$5.59 Million

Liability Composition Analysis (2013–2023)

This chart breaks down BioNeutra Global Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See BGA equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.35	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-2.65	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.61	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BioNeutra Global Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BioNeutra Global Corp (2013–2023)

The table below shows the annual total liabilities of BioNeutra Global Corp from 2013 to 2023.

Year	Total Liabilities	Change
2023-12-31	CA$21.96 Million ≈ $15.89 Million	-6.70%
2022-12-31	CA$23.54 Million ≈ $17.03 Million	+6.42%
2021-12-31	CA$22.12 Million ≈ $16.00 Million	-3.74%
2020-12-31	CA$22.98 Million ≈ $16.62 Million	-21.51%
2019-12-31	CA$29.27 Million ≈ $21.18 Million	+33.49%
2018-12-31	CA$21.93 Million ≈ $15.86 Million	+28.88%
2017-12-31	CA$17.01 Million ≈ $12.31 Million	-18.26%
2016-12-31	CA$20.81 Million ≈ $15.06 Million	+79.56%
2015-12-31	CA$11.59 Million ≈ $8.39 Million	+263.80%
2014-12-31	CA$3.19 Million ≈ $2.30 Million	-25.00%
2013-12-31	CA$4.25 Million ≈ $3.07 Million	--

About BioNeutra Global Corp

V:BGA Canada Packaged Foods

Market Cap

$1.01 Million

CA$1.39 Million CAD

Market Cap Rank

#30684 Global

#1580 in Canada

Share Price

CA$0.03

Change (1 day)

+0.00%

52-Week Range

CA$0.03 - CA$0.03

All Time High

CA$0.90